Revenue: The sum of all revenue fields included for a company's operating activities.
Assembly Biosciences, Inc. (ASMB) had Revenue of $28.52M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
$28.52M |
$-40.18M |
|
-- |
|
$28.52M |
|
$73.94M |
|
$-45.42M |
|
$5.57M |
|
$-39.85M |
|
$-39.85M |
|
$-40.18M |
|
$-40.18M |
|
$-40.18M |
|
$-40.18M |
|
$-45.42M |
|
$-48.95M |
|
6.00M |
|
6.00M |
|
$-6.69 |
|
$-6.69 |
|
Balance Sheet Financials | |
$115.50M |
|
$0.28M |
|
$3.67M |
|
$119.17M |
|
$47.80M |
|
-- |
|
$38.01M |
|
$85.81M |
|
$33.36M |
|
$33.36M |
|
$33.36M |
|
7.46M |
|
Cash Flow Statement Financials | |
$-51.12M |
|
$40.17M |
|
$29.45M |
|
$19.84M |
|
$38.34M |
|
$18.50M |
|
$3.12M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-159.26% |
|
-159.26% |
|
-171.63% |
|
-139.72% |
|
-140.87% |
|
$-51.15M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
-- |
|
-- |
|
-- |
|
-120.44% |
|
-120.44% |
|
-33.71% |
|
-120.44% |
|
$4.47 |
|
$-8.52 |
|
$-8.51 |